Regulatory & Legal

REPKON USA rebrands as Paligen, signaling a new era of domestic defense manufacturing fueled by a landmark TNT contract and strategic acquisitions.

A new report shows automakers are racing to innovate with AI, but a troubling decline in safety standard adherence puts the industry at a critical crossroads.

A new AI biomarker analyzes blood vessels in CT scans, offering earlier, more accurate predictions of which patients will benefit from immunotherapy.

Promising results for bladder cancer therapy TARA-002, key FDA designations, and a $198M cash runway position Protara for a pivotal year.

With NCQA Prevalidation for its ARC platform, COPE Health Solutions offers health plans a streamlined path to accreditation and a trusted tool for VBC.

The insurer posted strong 2025 results, with core underwriting gains and niche market growth overshadowing a $15.7 million hit from California fires.

In a strategic move to fortify national security, X-Bow is acquiring Evolution Space, boosting US rocket motor production and hypersonic capabilities.

Quantum firm Zapata adds industry veterans to its board, signaling a strategic shift in the quantum race from hardware supremacy to software application.

With its novel glaucoma drug QLS-111 entering Phase 3, Qlaris Bio brings in seasoned leader Fred Guerard to navigate the final trials and path to market.

With its CAR-T therapy achieving franchise profitability and treating 10,000 patients, Legend Biotech eyes overall profit and next-gen cancer treatments.

PowerBank Corp. secures millions in state funding to build a community solar farm on a former industrial site, promising lower energy bills for 875 homes.

Celebrating 80 years, Aveeno renews its foundational ties with Mayo Clinic, launching a new era of oat science research for compromised skin.

A landmark deal between Diverso and Dandelion Energy aims to make geothermal a standard utility in new homes, removing cost barriers for builders and buyers.

A new industry report claims mining for green minerals is low-emission, but reveals the real climate fight is decarbonizing steel and aluminum production.

Uranium Energy Corp reports a strong quarter with new mine completion, robust finances, and a strategic push to build a fully domestic nuclear fuel cycle.

A global consortium pioneers new drugs designed specifically for children, moving away from harsh adult treatments for aggressive pediatric cancers.

A new study reveals Canadians lost billions in wages waiting for care. This is the staggering personal and economic cost of the nation's healthcare queues.

K-pop sensation Kim Sejeong is the new face of REJURAN, a move merging celebrity appeal with advanced skin science to expand K-beauty's global reach.

OSE Immunotherapeutics confirms Marc Le Bozec as CEO, betting on his turnaround expertise to navigate market pressures and commercialize its key therapies.

A former space program manager is tackling a new frontier: teaching AI to everyone from academics to seniors, aiming to bridge a critical knowledge gap.